An integrative view of obesity

American Journal of Clinical Nutrition

Volumn 91, Issue 1, 2010, Pages

  Heber, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CD68 ANTIGEN; CHEMOKINE; CYTOKINE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT MEDICINAL PRODUCT; SPHINGOMYELIN PHOSPHODIESTERASE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL FAT; ADIPOCYTE; AUTOCRINE EFFECT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CELL INFILTRATION; CELL SIZE; CENTRAL NERVOUS SYSTEM; CHRONIC INFLAMMATION; CONFERENCE PAPER; DIET RESTRICTION; ENERGY BALANCE; ETHNIC GROUP; EXERCISE; FOOD INTAKE; FRUIT; GASTROINTESTINAL TRACT; GENE EXPRESSION; HEALTH HAZARD; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART STROKE VOLUME; HUMAN; IMMUNE SYSTEM; INSULIN RESISTANCE; LIFESTYLE; MACROPHAGE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITION; OBESITY; PALATABILITY; PARACRINE SIGNALING; PHYSICAL ACTIVITY; PSYCHOPHYSIOLOGY; PUBLIC HEALTH; SIGNAL TRANSDUCTION; STARVATION; VEGETABLE; WEIGHT CONTROL; WEIGHT REDUCTION; ADIPOSE TISSUE; ARTICLE; ENVIRONMENT; FOOD; HEALTH SURVEY; INFLAMMATION; INTEGRATIVE MEDICINE; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SOUTHEAST ASIA; STATISTICS; UNITED STATES;

ADIPOCYTES; ADIPOSE TISSUE; ASIA, SOUTHEASTERN; BODY MASS INDEX; ENVIRONMENT; EXERCISE; FOOD; HEALTH SURVEYS; HUMANS; INFLAMMATION; INTEGRATIVE MEDICINE; OBESITY; UNITED STATES;

EID: 74049150482     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28473B     Document Type: Conference Paper

References (37)

1. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962;14:353-62.
2. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004;79:774-9.
3. Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 2004;79:537-43.
4. Bray GA, Popkin BM. Dietary fat intake does affect obesity! Am J Clin Nutr 1998;68:1157-73.
5. Darmon N, Briend A, Drewnowski A. Energy dense diets are associated with lower diet costs: a community study of French adults. Public Health Nutr 2004;7:21-7.
6. Drewnowski A. Fat and sugar: an economic analysis. J Nutr 2003;133: 838S-40S.
7. Drewnowski A. Obesity and the food environment: dietary energy density and diet costs. Am J Prev Med 2004;94:1555-9.
8. World Health Organization. Diet, nutrition and the prevention of chronic diseases. Report of a joint WHO/FAO consultation. Geneva, Switzerland. 2003. Technical report 916. Available from: www.who.int/ dietphysicalactivity/ publications/trs916/intro/en/ (cited March 2009).
9. Brand-Miller JC, Holt SH. Australian Aboriginal plant foods: a consideration of their nutritional composition and health implications. Nutr Res Rev 1998;11:5-23.
10. Kant AK. Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 2000;72:929-36.
11. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science 2003;299:853-5.
12. Seidell JC. Obesity, insulin resistance and diabetes - a worldwide epidemic. Br J Nutr 2000;83(suppl 1):S5-8.
13. Bax JJ, van der Wall EE. Assessment of coronary artery disease in patients with (a)symptomatic diabetes. Eur Heart J 2006;27:631-2.
14. VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA. Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990; 52:953-9.
15. James WP, Lobstein T. BMI screening and surveillance: an international perspective. Pediatrics 2009;124(suppl 1):S42-9.
16. Heber D, Ingles S, Ashley JM, et al. Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Am J Clin Nutr 1996;64: 472S-7S.
17. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009;15:2920-6.
18. Krug AW, Ehrhart-Bornstein M. Newly discovered endocrine functions of white adipose tissue: possible relevance in obesity-related diseases. Cell Mol Life Sci 2005;62:1359-62.
19. Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277-86.
20. Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347-55.
21. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-808.
22. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-30.
23. Clement K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004;18:1657-69.
24. Tansey JT, Sztalryd C, Hlavin EM, Kimmel AR, Londos C. The central role of perilipin a in lipid metabolism and adipocyte lipolysis. IUBMB Life 2004;56:379-85.
25. Avram MM, Avram AS, James WD. Subcutaneous fat in normal and diseased states: 1. Introduction. J Am Acad Dermatol 2005;53:663-70.
26. Kolak M, Westerbacka J, Velagapudi VR, et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007;56: 1960-8.
27. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-4.
28. Li Z, Hong K, Saltsman P, et al. Long-term efficacy of soy-based meal replacements vs an individualized diet plan in obese type II DM patients: relative effects on weight loss, metabolic parameters, and C-reactive protein. Eur J Clin Nutr 2005;59:411-8.
29. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N Engl J Med 2002;346:393-403.
30. DeFuria J, Bennett G, Strissel KJ, et al. Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequellae. J Nutr 2009;139:1510-6.
31. Liu L, Nettleton JA, Bertoni AG, Bluemke DA, Lima JA, Szklo M. Dietary pattern, the metabolic syndrome, and left ventricular mass and systolic function: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 2009;90:362-8.
32. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005;28:2823-31.
33. Cohen-Cole E, Fletcher JM. Is obesity contagious? Social networks vs. environmental factors in the obesity epidemic. J Health Econ 2008;27: 1382-7.
34. Bornstein SR, Ehrhart-Bornstein M, Wong ML, Licinio J. Is the worldwide epidemic of obesity a communicable feature of globalization? Exp Clin Endocrinol Diabetes 2008;116(suppl 1):S30-2.
35. Apovian CM. The causes, prevalence, and treatment of obesity revisited in 2009: what have we learned so far? Am J Clin Nutr 2010;91(suppl): 277S-9S.
36. Popkin BM. Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr 2010; 91(suppl):284S-8S.
37. Blackburn GL, Wollner S, Heymsfield SB. Lifestyle interventions for the treatment of class III obesity: a primary target for nutrition medicine in the obesity epidemic. Am J Clin Nutr 2010;91(suppl):289S-92S.